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The expression of cornifin, a putative cross-linked envelope 
precursor, was investigated in several squamous differentiat-
ing tissues by in situ hybridization and immunohistochemical 
analysis. Cornifin mRNA and protein, which are absent in 
the normal mucociliary tracheal epithelium, are induced in 
the suprabasal layers of the squamous metaplastic tracheal 
epithelium of vitamin A - deficient hamsters. Similar to the 
induction of squamous metaplasia in villa, culture of rabbit 
tracheal cells in the absence of retinoids results in squamous 
differentiation and expression of cornifin. This induction of 
cornifin expression is suppressed by retinoic acid and several 
of its analogs. Cornifin mRNA and protein are also detected 
in the suprabasallayers of the squamous epithelium of rabbit 
esophagus and tongue. The distribution of cornifin in human 
epidermis was compared with that of two other crosslinked 
Squamous differentiation is a pathway of differentiation observed in many different tissues. In certain epithelia, including that of the epidermis, esophagus, and tongue, it constitutes the normal pathway of differentiation, whereas, in other tissues, including the epithelial lining of 
the major conducting airways, it occurs under pathologic conditions 
[1- 3]. Morphologic and biochemical studies have indicated that 
squamous differentiation is a multi-stage process and involves the 
sequential expression of many squamous cell-specific genes [3 - 5]. 
Four major stages of keratinocyte differentiation have been recog-
nized that correspond to the basal, spinous, granular, and cornified 
layers of the epidermis [1]. The formation of the cornified cell 
envelope (CE, synonymous with cross-linked cell envelope) is a 
characteristic feature at advanced stages of squamous differentia-
tion. The CE consists of a layer of cross-linked protein formed just 
beneath the plasma membrane [6-8]. The calcium-dependent en-
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envelope precursor proteins, involucrin and loricrin. The 
localization of cornifin and involucrin is very similar. Both 
are induced in the spinous layer and appear at an earlier stage 
during epidermal differentiation than loricrin. The expres-
sion of cornifin is greatly increased in psoriatic skin. Cornifin 
mRNA is barely detectable in normal epidermis, whereas it is 
present at relatively high levels in the suprabasal layers of 
psoriatic epidermis. Topical treatment with RA results in 
thickening of the skin and increases the level of cornifin 
mRNA and protein in the upper spinous layers of mouse skin. 
Cornifin expression correlates generally with squamous dif-
ferentiation in a variety of tissues and is abnormally regulated 
in psoriatic skin and in skin treated topically with retinoic 
acid. Key words: Involucrin, loricrin, trachea, crosslinked 
envelope.] 1mlest Derrnato1101:268-274, 1993 
zyme, transglutaminase type I, catalyzes the formation of y-gluta-
myl-e-lysine isopeptide bonds between specific envelope precursor 
proteins [9 -12]. Several proteins that function as envelope precur-
sors have been identified and characterized, including involucrin 
[9,13,14] and loricrin [15,16] . 
Recently, a gene family was identified that appears to encode a 
new group of cross-linked envelope precursors, named cornifins 
[17 -19]. These proteins act as substrates for transglutaminase type I 
and become integrated into the cross-linked envelope [17 -19]. The 
cornifins that we have recently described [19], and now refer to as 
type a cornifins, are rich in proline, glutamine, and cysteine and 
contain a tandem repeat of the consensus octapeptide EPCQPKVP 
at their C-terminus. These cornifins appear to be analogous to the 
small proline-rich protein SPR-1 [18]. The cornifin-a family con-
sists of subtypes that differ mainly in the number of octapeptide 
repeats (Marvin KM, Jetten AM, unpublished observations). The 
major cornifin-a subtype expressed in cultured rabbit tracheobron-
chial epithelial cells contains 13 of these repeats [19]. 
Many aspects of epithelial cell differentiation are modulated by 
retinoids [2,3]. In cultured epidermal keratinocytes, retinoids in-
hibit the expression of squamous-cell- specific genes [2,3,20 - 23]' 
In contrast, retinoids applied topically cause epidermal hyperplasia 
in rodents and humans, and increased expression of several differen-
tiation markers [23-26]. Retinoids also control the differentiation 
of tracheobronchial stem cells [3]. In vitamin A-deficient animals, 
the normal pscudostratified mucociliary epithelium in the trachea is 
replaced by a stratified, squamous epithelium [27,28]. This process 
is reversed by restoring vitamin A to the diet [29]. Similarly, reti-
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noids inhibit the expression of the squamous differentiated pheno-
type in cultured tracheobronchial epithelial cells [3,12,22,30]. 
In this study, we examine the distribution of cornifin mRNA and 
protein in differen~ squamous t~s5Ues by ill situ hybridization ~l1d 
immunohistochemistry, respectively. We show that both cormfin 
mRNA and protein are abundant in the suprabasal layers of the 
esophagus and tongue. I.n. contrast to the la.ck o~ cornifin express!on 
in the normal mucoclhary tracheal eplthehum, both cormfin 
mRNA and protein are detected in the squamous-differentiated 
tracheal epithelium of vitamin A-deficient hamsters. Comparison 
of cornifin expression in normal versus psoriatic skin shows an 
increase in the level of cornifin expression in the latter. In addition, 
w e demonstrate that both cornifin mRNA and protein are dramati-
cally induced in mouse skin treated topically with retinoic acid and 
compare the pattern of cornifin expressi.on with those of involucrin 
and loricrin in normal human epldernus. 
MATERIALS AND METHODS 
Cell Culture Rabbit tracheal epithelial (RbTE) cells were isolated and 
cultured as described [12]. Normal human epidermal keratinocytes (NHEK) 
were obtained from Clonetics (San Diego, CA) and cultured in keratinocyte 
growth medium (Clonetics) [21] . 
Reagents All-trans retinoic acid (RA), Ro 13-7410, Ro 40-6055 (Am 
580), Ro 18-6622, and the calcium ionophore Ro 2-2985 were obtained 
from Hoffmann-La Roche (Nutley, NJ). SRI 6751-84 and 9-cisretinoic acid 
were supplied by Dr. Marcia Dawson (SRI,.Menlo Park, CA). The benz~ic 
acid derivatives Ch55 and Ch20 were supplied by Dr. K. Shudo (Ul1lvemty 
of Tokyo). Uridine-5'-[a-35S]-thiotriphosphate was purchased from Amer-
sham Corporation. RNase:inhi~itor an? RNase-.free D~ase were obtained 
from Boehringer Mannhelm BIOchemicals (Indianapolis, IN). T3 and T7 
RNA polymerase were from Stratagene Cloning Systems (La Jolla, CA). 
Silanated glass slides were purchased from Digene Diagnostics, Inc. (Silver 
Spring, MD). The anti-Ioricrin antiserum was a gift from Dr. Dennis Roop 
(Baylor College, Houston, TX). The anti-involucrin was obtained from Dr. 
G. Moore, Yale University, New Haven. 
Immunoblot Analysis Cultured cell extracts for immunoblot analysis 
were prepared as described ~reviously [19]. Specime.ns taken ~roI? rabbit 
tongue, lip, esophagus, and liver were frozen Immediately 111 liqUid I1ltro-
gen. The squamous epithelial layers of the fro~en tissues were scraped and 
collected in 1 ml extraction buffer (0.05 M Tns, pH 7.5, 1 % NP40, 2 mM 
phenylmethylsulfonylfluoride, 0.5 mM ethylenediaminetetraacetic acid, 
and 10 )lg/ml of pepstatin A, antipain, leupeptin, and chymostatin). Tissues 
were homogenized by sonication, and the homogenates centrifuged at 
100,000 X g for 1 hat 4 · C . The supernatants were mixed with! volume of 
3 X sodium dodecylsulfate sample buffer [32], heated for 5 min at 95·C and 
stored at -70·C. Immunoblot analysis was performed as described using 
anti-cornifin (SQ37A-Ab or SQ37B-Ab) antiserum [19,31]. 
Tissues Rabbit tissues were taken from the tongue and from the esopha-
gus. Normal human skin was obtained from plastic surgery. Biopsies were 
taken from involved skin of four different psoriatic patients. Tracheas were 
obtained from male Syrian golden hamsters maintained either on a semisyn-
thetic, retinoic acid - containing (3 )lg/ g) diet (Teklad, Madison, WI) for 
life (retinoid-sufficient hamsters), or on the same diet without retinoic acid 
from birth, until they began to lose weight, and then cycled for 18 d on the 
retinoid-supplemented diet followed by 10 d on the retinoid-deficient diet 
[28]. Deficient hamsters used in this study were maintained on a retinoid-de-
ficient diet for 33 d following 13 dietary cycles. Hamsters were perfused and 
tissues fixed as described below. Biopsies of dorsal skin from Skh-hr1 mice 
were treated topically with a single retinoic acid application (25 )lg retinoic 
acid in 0.1 ml acetone) 3 d per week for 6 weeks, or with vehicle only. Mice 
were perfused with 4% paraformaldehyde/O.l M phosphate buffer (PBS) as 
described [33] before skin specimens were taken. All tissue specimens were 
fixed in the same fixative for an additional 3 h, then washed in PBS and 
dehydrated through a graded series of ethanol. After incubation in xylene 
(three times for 15 min), the tissues were embedded in Paraplast (Monoject 
Scientific) [33]. 
Probe Preparation The plasmid SQ37 -1 containing a 660-base fragment 
of cornifin cDNA was linearized at unique restriction sites in the multiple 
cloning region of the vector and transcribed from the T7 and T3 RNA 
polymerase promoter to generate the antisense and sense probes, respec-
tively. In vitro transcription was performed with 30 )lCi of uridinc 5'_[a_35S] 
th iotriphosphate and 1.0 )lg of linearized DNA (specific activity 5- 8 X 108 
cpm/ )lg). After the removal of unincorporated labeled nucleotide, probes for 
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hybridization were subjected to limited alkaline hydrolysis to reduce the size 
of transcript to about 150 nucleotides. 
In Situ Hybridization Paraffin sections (5-)lm thick) were deparaffinized 
111 xylene and rehydrated through a graded series of ethanol. Sections were 
then immersed two times for 10 min in PBS containing glycine (2 mg/ml) 
and then acetylated for 15 min at room temperature in 0.1 M triethanol-
amine, pH 8.0, 0.25% (v/v) acetic anhydride. After rinsing two times in 
2 X sodium citrate/sodium chloride buffer (SSe) for 10 min, the sections 
were pre-hybridized in 50% formamide, 2 X SSC, 10 mM dithiothreitol for 
30 min at 50· C. For hybridization, the labeled probe was mixed with an 
aliquot of hybridization solution (50% deionized formamide 2 X SSC 10% 
. dextran sulfa.te, 10 mM dithiothreitol, 4 mg/ml bovine s~rum alb~min, 
2 mg/ml s?l11cated salmon sperm DNA, and 2 mg/ml tRNA) to give a final 
concentration of 5 X 104 • dpm/)ll. After aspirating the pre-hybridization 
solutIOn, 30 /11 of probe rmxture was applied on each slide and hybridization 
performed at 47 · C for 16 h. The sections were then washed three times in 
2 X SSC, 50% formamide, 10 mM dithiothreitol for 20 min at 55 · C. Non-
specifically .bound prob~ was hydrolyzed by incubation with RNaseA 
(40 )lg(ml).ml0 mM Tns pH 8.0, 0.5 M N aC!, 1 mM ethylenediaminete-
traacetlc aCid for 30 mm at 37"C. The sections were washed in 2 X SSC, 
50% formam:de for 30 min at 55· C, and subsequently in 2 X SSC for 1 hat 
room temperature. The sections were then dehydrated by incubation 
~hrough a. graded senes ~f ethanol. For autoradiography, the slides were 
Immersed ll1 NTB2 emulSIOn (Kodak) diluted 1 : 1.3 with distilled water and 
then air d~ed for 20 min. After 1-2 weeks exposure at 4 · C in a light-tight 
box, the shdes were developed and counterstained with hematoxylin [33]. 
Im~unohistoch.emical Staining Paraffin sections (5 /1m) were depar-
aHil1lzed as descnbed above for ill sitll hybridization. The sections were 
incuba.ted. with blocking solution (7.5% milk powder, 1 % bovine serum 
albumm III PBS) for 60 min, and then for 60 min with a thousandfold 
?ilution of anti-corn~fin (SQ37~-Ab or SQ37B-Ab) antiserum [19) or pre-
Immune serum, or With a 500-tlmes dilution of anti-Ioricrin or anti-involu-
crin antiserum in blocking solutin. Subsequently, tissue sections were incu-
bated for. 60 min first with biotinylated goat-anti-rabbit IgG (Jackson 
Laboratones) and then With streptavidin-horseradish peroxidase (Jackson 
Laborato.nes) . Immunoreactivity was visualized using diaminobenzidine. 
The sectIOns were counterstained with 1 % methyl green. 
RESULTS 
Induction of Corni6n Expression in Tracheas of Vitamin 
A-De6cient Hamsters The cDNA clone SQ37 encoding cor-
nifin was isola~ed fro~ a cDNA library made from poly(A)+ RNA 
of squamous-~Ifferentlated rabbit tracheal epithelial cells [17]. We 
reported preViously that cultured rabbit tracheal epithelial cells 
begin .to .synthesize cornifin when cultures undergo squamous dif-
ferentlatlOn at confluence [19] . To study the expression of cornifin 
in tracheal epithelial cells hI situ, we used tracheas from retinoid-
sufficient and -deficient ~a~sters [28] . The epithelial lining of tra-
cheas from hamsters ma1l1~a1l1ed on a retinoid-supplemented diet is 
pseudostratlfied and co~ta1l1s b~sal , mucous, and ciliated cells (Fig 
lA). ~owe~er, a ret1l10l~-deficlent diet converts the pseudostrati-
fie.d eplthehum to a stratlfied, squamous-differentiated epithelium 
(Fig IE). We first exam1l1ed the presence of cornifin mRNA in 
these tracheas by ill situ hybridization using an 35S-1abeled ribo-~robe. ~n cont~ast t~ the nO~l11al pseudostratified tracheal epithe-
hum (Fig le), 111 wluch cor111fin mRNA was undetectable cornifin 
mRNA was dete~ted i.n the suprabasallayers of the stratifi~d, squa-
mous tr~cheal ~p~thelium of retinoid-deficient hamsters (Fig ID). 
No speclfi.c sta1l1111~ was ob.served with the sense probe (Fig lE). 
Immunohistochellllcal studies confirmed that cornifin is not ex-
pressed in the normal tracheal epithelium (Fig IF) but was present 
111 the su~rabasal layers of.the squamous tracheal epithelium (Fig 
1~). P~e-Im~une serum dld not stain the squamous differentiated 
eplthelium (Flg IH). These results demonstrate that the induction 
o~ squamous differentiation in the tracheal epithelium correlates 
With the appearance of cornifin expression. 
I:s ~as .be~n . demonstrated for tracheal epithelial cells ill vivo, 
ret1l101ds mhlblt squamous cell differentiation of cultured tracheo-
bronchial epithelial cells [3]. This inhibition is apparent in the de-
creased expression of squamous cell-specific genes, including those 
encoding transglutaminase type I, cornifin, and cholesterol sulfo-
transferase [12,17,19,22,34]. In squamous differentiated rabbit tra-
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Figure 1. Distribution of cornifin mRNA and protein in tracheas from 
vitamin A-sufficient and -defi cient hamsters. Hcmatoxylin and eosin 
staining of norma l pseudostratificd (A) and hypcrplastic squamous-differ-
entiatcd (B) trachea. III siw hybridization with thc anti-sense cornifin ribo-
probe SQ37-1 of normal (C) and squamous-diffe rcntiated (D) trachca. III 
sil.1I hybrid iza tion of hyperplastic, squamous-differcntiated trachea with thc 
control, scnsc, cornifin SQ37-1 riboprobc (E). Immunohistochemical stain-
ing with an'ti-cornifin antiserum (SQ37 A-Ab) of control (F) and squamous-
differcntiatcd (G) trachea. Immunohistochcmical staining of squamous-dif-
fercntiated trachea wi th prcimmune seru m (H). Bar, 50 j.l.m. A rrows, 
derma l/cpidermal junction. 
cheal epithelial ce lls, the an ti-cornifin antibody SQ3 7 A-Ab recog-
nizes a protein migrating with an appare nt molecu lar weight of 
23 kD (Fig 2, la/I e 1) [1 9]. The immunoreactivity at the top of th e 
gel represents cornifin covalently linked to hi gh-molecular com-
plexes [1 9]. All-trans reti noic acid and several of its benzoic acid 
analogs , C h55 and SRI 6751-84 (RAR-selective analogs), Ro 13-
74 10, Ro 40-6055 (an RARa-selective ana log), and Ro 18-6622, 
were eac h effective in inhibiting the induction of cornifin in cul-
tured rabbit tracheal epithelial cell s (Fig 2). The benzoic acid analog 
C h20 was re latively ineffective in suppressing corni fin expression. 
The 9-cis isomer of re tinoic acid , which can bind to and ac tivate 
both RAR and RXR receptors, was also active but less so than the 
all -trans isomer. Retinoids also reduced the level of immunoreac-
tive, high - molecu lar-weight protein. The latter is probably related 
to a reduced cornifin synthesis as well as to a retinoid-induced inhi-
bition of transglutaminase type I syn thesis, which catal yzes the 
cross-linking of cornifin [1 2 ,1 9,22]. 
Corni6.n Expression in Rabbit Esophagus and Tongue III 
sifl.l hybridization was used to localize cornifin mRNA in sections 
fro m two other squamous t issues, name ly rabbit esophagus and 
tongue. In the esophagus the il1 situ hybridizatio n staining pattern 
obtained with the 35S- labeled SQ37-1 an ti-sense riboprobe shows 
that the presence of cornifin mRNA was restricted to cells in the 
suprabasallayers and was undetectable in cells of the basal and cor-
nified layers (Fig 3A). The labe li ng was specific, as demonstrated by 
the absence of a specific hybridizat ion signal in sections hybridized 
to the sense riboprobe (Fig 3B). 
Immuno histochemical staining of sections from the rabbit 
esophagus w ith the antiserum SQ37 A-Ab revealed that cornifin 
protein was prese nt in the suprabasal layers but that the basal and 
corn ified layers were not immunoreactive (Fig 3C) . Figure 3D,E 
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Figure 2. Suppression of cornifin induction by different retinoids. Con. 
f1ucnt cul tures of squamous-differentiated RbTE cells were treated with 
different retinoids for 4 d at 10- 8 M . Cel lular extracts (20 j.l.g of protein 
loaded per lalle) were exam ined under reducing conditions by immunoblot 
analysis using SQ37 A-Ab. RA, all-trans retinoic acid; 9-cis RA binds to 
RARs and RXRs; Ro 13-7410, SRI 6751-84 and Ch55 , are RAR-selective 
analogs; Ch20 is an inactive retinoid; Ro 40-6055 is an RARa-selective 
analog. 
shows the distribution of comilln mRNA in the rabbit tongue. 
Again, significant accumul ation of cornifin mRNA was observed in 
the suprabasallayers (Fig 3D) . The highest level of cornifin mRNA 
was observed in the spinous layer and the level of expression de-
creased in the upper keratinocyte layers. Immunohistochemical 
staining showed that expression of cornifin protein was restricted to 
the spinous and gra nul ar layers of the tongue epithelium (Fig 3F). 
Expression of Different Corni6.n Protein Because cornifin 
appears to consist of a family of related proteins [18,19], we ne}"l: 
examined whether different ti ssues expressed different corn.illns. 
The type a cornifins differ from each other mainly in the length of 
their tandem repeats (Marvin KM, J etten AM, unpublished obser-
vations). The presence of different cornifins was examined by im-
munoblot analysis in extracts from rabbit tongue, lip, esophagus, 
and liver. In extracts from to ngue, lip, and esophagus the SQ37 A-
Ab (Fig 4) and SQ37B-Ab (not shown) recognized two major pro-
teins with apparent molecular masses of 23 and 26 kD. In extract 
from rabbit tongue an additional protein with an apparent molecu-
lar mass of 18 kD reacted with the anticornifin antibody. Squamou 
differentiated rabbit tracheobronchial epithelial cells in culture pri-
marily expressed cornifins with an apparent molecular mass of 23 
and 18 kD, in agree ment with previous resu lts [19]. No immunore-
active proteins were detected in extracts from rabbit liver. The exis· 
tence of a fa mily of genes encoding cornifins of different molecular 
mass (Marvin KM, J etten AM, unpublished observations) and the 
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Figure 3. Distribution of comifin mRNA and protein in ~abbit tissues. III 
sitll hybridization of sections .of the esophagus (A) and the tiP of the tongue 
(D) with the anti-sense cormfin nboprobe SQ37-1 . III SI (I/ hybridiza tIOn of 
sections of esophagus (B) and tongue (E) with a sense probe. Immunoper-
.oxidase staining with anti-cornifin antiserum (SQ3 7 A-Ab) of the esophag us 
(C) and tip of tongue (F). Bar, 100 tim. A rrows, basement membrane. 
- fac t that great care was taken to prevent proteolysis during the 
preparation of th e extracts sUl?ports the 111terpretatlon that th e dif-
ferent immunoreactive prote111s expressed 111 the different tissues 
represent cornifins of different size. 
Comparison of th~ P~ttern of Expressio~ of C.ornifin,. Invo-
lucrin, and Loricr1O 10 the Normal Epidermis PreVIOusly, 
we reported the localization of cornifin in human epidermiS [19]. In 
this study, we compared its localization with that of l11volucnn and 
loricrin. Immunohistochenuca l studies revealed that the Immuno-
reactivity with the anti -cornifin antibody SQ37 A-Ab is restricted to 
the uppermost spinous layer s.and the granul ar layers of the normal 
epidermis (Fig 5A) . No sta111~ng was observed 111 the dernllS. Invo-
lucrin exrression ocurred a little earher than that of cor11lfin (Fig 
5B) [9 ,35J, whereas the react ivity with anti-loricrin antibodies ~as 
later and restricted to the granular layers, 111 agreement With 
previous reports (Fig 5C) [16] . r:-r0 orsignifica.ntly reduced.immu-
noreactivity with the ant l-corl1lfin, -u1Volucnn, or -Ion cnn an ti-
bodies was observed in the cornified layers. This is probably due to 
the loss of the epitopes due to crosslinking and/or decreased accessI-
bility of the antibodies to the epitopes of the envelope precursors 
w hen they become assembled 111 to the envelope. Our results suggest 
that cornifin is induced at a similar time during th e process of squa-
mous differentiation as involucrin and is synthesized at an earlier 
stage than loricrin. . 
The cross-linking of the envelope precursors IS cata lyzed by th e 
Ca++-dependent transglutaminase type I, which can be ac tivated 111 
cells by calcium ionophore treatment [9,11,19J . To exa m111e th e 
cross-linking of corl1lfin 111 NHEK cells, we treated confluent cu l-
tures of NHEK cells with the Ca++ ionophore Ro 2-2985 (25 J.lg/ 
ml) for 3 h before cells were harvested and examined the cellular 
proteins by immunoblot analysis using th e anticornifin antiserum 
SQ37B-Ab. This antiserum recognized a protein with an apparent 
molecular mass of 15 kD in total cellular and soluble fractIOns of 
differentiated NHEK ce lls but not in particulate fractions (Fig 6) . 
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Figure 4. Express ion of corn ifin isoforms in different rabbit tissues. Ex-
tracts from the epithelium of rabbit tongue (Ialle 1), lip (Ialle 2), esophagus 
(Ialle 3) , liver (Ialle 4), and cultured squamous differentiated RbTE ce ll s (Ialle 
5) were examined by im111unoblor ana lysis using SQ37 A-Ab. The molecular 
mass (kD) of protein standards is indicated on the right. 
These results are in agreement with the cytoso lic loca lization of 
corn ifin observed in immunohistochemical sections. In extracts 
from cells treated with Ca++-ionophore the reaction of this protein 
with the antibody alnJost disappeared (Fig 6), in agreement wi th the 
loss of immunoreactive sites after cornifi n becomes crosslinked by 
transglutaminase into high - molecular-weight complexes, as has 
been demonstrated for rabbit cornifin [1 9]. 
Corni6n mRNA and Protein in Normal Versus Psoriatic 
Epidermis We next compared the expression of cornifin in nor-
mal and psoriatic skin. In normal human skin, specific ill silll hy-
bridization signals were barely detectable (not shown) , whereas in 
psoriatic epidermis cornifin mRNA was abundant in the spinous 
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Figure 5. Comparison of the localization of cornifin, involucrin, and lori-
crin in nOl"mal human sk in . Sections of normal human skin were stained 
with anti-cornifin antiserum (SQ37 A-Ab) (A), anti- involucrin antiserulll 
(B), anti-I oric rin antiserum (C) . Bar, 50 pill . Arrows, dennaIjepidermal 
junctio n. Arrowlwads, melanin pigments. 
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Figure 6. Induction of cross-linking of cornifin by calcium ionophore. 
Confluent cultures of squamous-differentiated NHEK cells were treated 
with the calcium ionophore Ro 2-2985 (25 I1g/ml in DMSO) or DMSO (-) 
for 3 h before total cellular (T), soluble (S), and particulate (P) fractions were 
prepared. Protein of each of these fractions were analyzed by immunoblot 
analysis using anti-cornifin antiserum SQ37B-Ab. 
layers (Fig 7 A). The increased expression of cornifin in psoriatic 
skin was confirmed by immunohistochemical studies demonstrat-
ing the presence of abundant cornifin protein in psoriatic epidermis 
(Fig 7C). In the rete ridge areas, the expression of cornifin was 
observed in several layers above the basal cell layer, whereas in the 
juxtapapillar areas, cornifin was detected directly suprabasally. 
Effect of Topical RA on Cornifin Expression in Mouse 
Epidermis Topical treatment of mouse and human skin with RA 
is known to result in thickening of the suprabasal cell layer and 
increased expression of several squamous cell markers [24-26]. To 
examine the effect of topical RA on cornifin expression, we used the 
skin of the hairless mouse (skh-hrl) as a model system [25]. Cornifin 
mRNA W;lS barely detectable in vehicle-treated skin (Fig BA). Ex-
pression of cornifin was significantly increased in the spinous and 
granular layers of the hyperplastic skin induced after topical treat-
ment with RA (Fig BE). Immunohistochemical analysis showed 
that cornifin protein was abundant in the upper spinous and granu-
lar layers of the hyperplastic mouse skin (Fig BE), whereas it was 
present at low levels in vehicle-treated skin (Fig BD). 
DISCUSSION 
In this study, we show that cornifin is expressed in vivo in squamous 
differentiated tissues, including rabbit esophagus and tongue, 
human and mouse epidermis, and metaplastic hamster trachea. Im-
munoblot analysis of cellular extracts indicated that keratinocytes 
from different tissues synthesize more than one form of cornifin. 
The anti-cornifin antiserum (SQ37 A-Ab) recognized rwo major 
proteins with an apparent molecular mass of 26 kD and 23 kD in 
extracts from the rabbit tongue, lip, and esophagus and an additional 
immunoreactive protein of IB kD in extracts from the tongue, 
whereas squamous differentiated rabbit tracheal cells expressed pri-
Figure 7. Increased expression of cornifin mRNA and protein in human 
psoriatic skin. In situ hybridization of sections of psoriatic skin with the 
anti-sense (A) and sense (B) cornifin riboprobe. Immunoperoxidase staining 
of a section of psoriatic skin with anti-cornifin antiserum SQ37 A-Ab (C). 
Bar, 100 11m. Arrows, dermal/epidermal junction. 
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Figure 8. Effect of topical RA on cornifin mRN A and protein expression in 
mouse skin. In sittl hybridization of sections of vehicle-treated skin (A) and 
RA-treated, hyperplastic skin (B) with the anti-sense cornifin riboprobe. III 
situ hybridization of sections from RA-treated, hyperplastic skin (c) with 
the control sense probe. Immunohistochemical staining of sections of vehi-
cle-treated skin (D) and RA-treated, hyperplastic skin (E) with anti-cornifin 
antiserum SQ37 A-Ab. Immunohistochemical staining of sections from RA-
treated, hyperplastic skin with preimmune serum (F) . Bar, 50 11m. Arrows, 
dermalj epidermal junction. 
marily the 23- and IB-kD cornifins. Cornifins are a family of genes 
consisting of several types and subtypes [lB, 19] (Marvin KW, Voll-
berg TM, Jetten AM, unpublished observations). DNA sequence 
analyses indicate that cornifins vary in the length and sequence of 
the amino acid repeats at the C-terminus. The several proteins rec-
ognized by SQ37 A-Ab may represent different members of the type 
a cornifin [19] . 
In the squamous differentiated tissues examined both cornifin 
protein and mRNA were localized in the upper spinous and granu-
lar layers. A sharp boundary was observed berween immunoreactive 
cells in the suprabasal cell layers and the first rwo or three layers of 
negative cells on the basal side of the epithelium. In the rabbit 
tongue epithelium, the cornifin mRNA appeared to be more abun-
dant in the suprabasallayers just above the basal cell layer than in the 
upper spinous layers. Our findings are consistent with previous data 
indicating that the expression of cornifin mRN A is limited to squa-
mous differentiating cells [16] . 
In normal human epidermis, cornifin protein is first detectable by 
immunohistochemical analyses in the upper spinous layer and con-
tinues to be expressed in the cells of the granular layer. The absence 
of immunoreactive cornifin in the cornified layer is probably due to 
the inability of the anti-cornifin antibodies to bind to epitopes when 
cornifin becomes crosslinked into the cornified envelope [16] . A 
similar loss of immunoreactivity is observed when cultured squa-
mous differentiated NHEK cells are treated with Ca++-ionophore, 
which causes the transglutaminase-catalyzed integration of cornifin 
into crosslinked envelopes. The distribution of corniful protein and 
mRNA in skin is very similar to that reported for involucrin [35,36]. 
Both cornifin and involucrin are induced at an earlier stage during 
epidermal differentiation than loricrin, the expression of which is 
limited to the granular and cornified layers [15,16]. The sequential 
induction of different envelope precursors supports the hypothesis 
that the formation of the cornified envelope occurs as a multistep 
process [19,37]. Keratinocytes in monolayer culture do not produce 
loricrin but are able to form cross-linked envelopes that are, how-
ever, much thinner than ones formed spontaneously in l!illO [37]' 
Cornifin and involucrin may be crosslinked at an early stage during 
the formation of the cross-linked envelope, creating a thin, imma-
ture envelope that functions as a scaffold upon which loricrin and 
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other envelope precursors are assemb~ed. Because the c:osslinking 
of cornifin is catalyzed by transglutam111ase type I, one might expect 
that the induction of these genes is closely coordinated. Comparison 
of the distribution of cornifin and transglutaminase mRNA in 
esophagus and epidermis shows that they co-localize in very much 
the same layers l43]. 
Psoriatic epidermis is characterized by a rapid turnover of kerati-
nocytes and an abnormal sequence of differentiation [35,38 - 40]. 
The latter results in the formation of a hyperplastic spinous layer, an 
abnormal nucleated cornified layer, and the absence of a granular 
layer. The abnormal differentiation is associated with ~Itered ex-
pression of squamous cell markers [35,39,40,43]. Kerat111s Kl and 
KI0 are reduced in psoriatic epidermis, ~hereas expression ?f K6 
and K16 is induced l41,42] . Our observations on the expresSIOn of 
cornifin are further evidence for an abnormal control of squamous 
differentiation in psoriatic epidermis. Our study demonstrates that, 
compared to normal s~in, the. le.vel of cornifin m~NA an~ I.'rot~in 
are greatly increase? 111 psonatlc epI?ermls. III SI.tu hybndlzatlOn 
showed relatively high levels of corlllfin mRNA 111 the suprabasal 
layers of psoriatic epidermis, where~s cOf?ifin mRNA was barely 
detectable in the normal human epidermis. These results suggest 
that in psoriatic skin cornifin is expressed in more cell layers and at 
an increased level compared to normal skin. The abundant expres-
sion of cornifin observed by immunoperoxidase staining was very 
similar to the expression of involucrin in psoriatic skin [35,39,40]. 
> Transglutaminase I mRNA an~ protein are ~Is~ greatly enhanced in 
psoriatic skin a.nd appe~r to be I?duced at a s111ular stage of differen-
tiation as corlllfin and 111volucnn [43] . 
In vitro, retinoids have been shown to specifically inhibit the 
expression of many squamous cell-specific genes, including keratin 
1 and 10 [2,5], cholesterol sulfotransferase [44], type I transgluta-
minase [21- 23], cornifin (Fig 2) [19], involucrin [45], and loricrin 
- [46,47]. In the tracheobronchial epithelium, vitamin A deficiency 
results in the replacement of the mucous and clhated cells by squa-
mous metaplastic cells [27 - 29]. Prev~ously, we have demon.strated 
that induction of squamous metaplasia 111 hamster tracheas IS asso-
ciated with the expression of transglutaminase type I in the supraba-
sal layers [30]. In this study, we show the induction of cornifin 
mRNA and protein in the suprabasal layers of the squamous-differ-
entiating tracheal epithelium. In analogy to squamous metaplasia of 
the tracheobronchial epithelium in vivo, squamous differentiation in 
cultured tracheobronchial epithelial cells cultured in the absence of 
retinoids is accompanied by the induction of cornifin protein and 
mRNA [19]. In both instances, retinoids inhib.ited the sq.uamo~s 
differentiation process and repressed the expressIOn of cortufin (Fig 
2) [19,27,30]. The suppression of cornifin expression in differen-
tiating RbTE cells was dependent on the structure of the retinoid. 
The analog CH20, which does not bind to the nuclear retinoid 
receptors RAR or RXR (Jetten AM, unpublis.hed observ~tions), was 
inactive. We have proposed that the repressIOn of corlllfin expres-
sion is mediated either directly or indirectly by RARs and/or RXRs 
[3,45,48-50]. The analogs Ch55 and S~I 6751-84, which are 
RAR-specific analogs (Jetten AM, unpubltshed observatIOns) and 
Ro 40-6055, an RARa-selective analog, are very potent in sup-
pressing cornifin expression. Although t~lis re.sult does not rule out 
the involvement of RXR receptors 111 thiS action, It appears to sug-
gest that RXR-Iigand interactions are not required. 
Chronic topical application of retinoic acid has been reported to 
cause thickening of the skin and to alter the expression of several 
differentiation markers in the epidermis [26,51,52]. These alter-
ations include the induction of keratins K13 and K6 and an increase 
in the number of cell layers expressing involucrin, transglutaminase 
type I, and CRABPII [26,51,52]. In this study, we show that in 
mouse skin chronic topical treatment with retinoic acid increases 
cornifin expression. Not only were cornifin mRNA and protein 
present over a larger number oflayers but the level of expression was 
also increased. The increased expression of cornifin and other squa-
mous cell-specific genes in skin topically treated with retinoic acid 
contrasts with the suppressive effect of retinoic acid on these differ-
entiation markers observed in cultured epidermal keratinocytes 
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[19]. The differential effects of retinoic acid on the expression of 
these genes in vivo and in vitro may reflect the complex control of 
epidermal differentiation ill vivo. Several additional factors have 
been reported to be important in the regulation of epidermal differ-
entiation, such as extracellular matrix components and interactions 
between epidermal keratinocytes and dermal or inflammatory cells 
[3 - 5]. Furthermore, different families of growth and differentia-
tion regulatory factors (polypeptide growth factors, cytokines) pro-
duced either by the keratinocyte or by dermal or inflammatory cells 
may also be involved [3 - 5,53]. Many of these factors are absent in 
monolayer cultures of keratinocytes and therefore cannot playa role 
. in the squamous differentiation of cultured keratinocytes. Finally, 
the metabo!ism of retinoids or the interaction of the retinoid signal 
pathway With that of other hormones such as vitamin D3 may also 
contribute to the differential effects of retinoids i,., Ilitro and in vivo. 
Ongoing studies analyzing the promoter region of cornifin and its 
regulatory elen:'ents may lead to a better understanding of the inter-
play of the vanous regulatory factors on squamous differentiation. 
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